Eosinophilic Lung Disease

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Eosinophils are involved in the pathogenesis of a number of lung diseases. Recent advances in eosinophil biology have now produced clinically applicable therapies that seek to counter eosinophilia in blood and lungs. This article reviews the basic biology of eosinophils and their role in mediating T-helper 2 cell responses. The current status of anticytokine therapy for eosinophilic lung disease is discussed. A clinical approach to eosinophilic lung disease based on symptoms and radiography is generated. The clinical significance of persistent eosinophilia in lung transplant patients and patients with asthma will receive special emphasis.

Original languageEnglish (US)
Pages (from-to)339-349
Number of pages11
JournalThe American journal of the medical sciences
Volume354
Issue number4
DOIs
StatePublished - Oct 1 2017

Fingerprint

Eosinophils
Lung Diseases
Eosinophilia
Lung
Th2 Cells
Radiography
Asthma
Transplants
Therapeutics

Keywords

  • Asthma
  • Eosinophils
  • Hypereosinophilic syndrome
  • Interleukin 5
  • Lung allograft rejection

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Eosinophilic Lung Disease. / Weissler, Jonathan C.

In: The American journal of the medical sciences, Vol. 354, No. 4, 01.10.2017, p. 339-349.

Research output: Contribution to journalReview article

@article{dd1a83c6c2bf49dbb6fa970914069789,
title = "Eosinophilic Lung Disease",
abstract = "Eosinophils are involved in the pathogenesis of a number of lung diseases. Recent advances in eosinophil biology have now produced clinically applicable therapies that seek to counter eosinophilia in blood and lungs. This article reviews the basic biology of eosinophils and their role in mediating T-helper 2 cell responses. The current status of anticytokine therapy for eosinophilic lung disease is discussed. A clinical approach to eosinophilic lung disease based on symptoms and radiography is generated. The clinical significance of persistent eosinophilia in lung transplant patients and patients with asthma will receive special emphasis.",
keywords = "Asthma, Eosinophils, Hypereosinophilic syndrome, Interleukin 5, Lung allograft rejection",
author = "Weissler, {Jonathan C.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.amjms.2017.03.020",
language = "English (US)",
volume = "354",
pages = "339--349",
journal = "The American journal of the medical sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Eosinophilic Lung Disease

AU - Weissler, Jonathan C.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Eosinophils are involved in the pathogenesis of a number of lung diseases. Recent advances in eosinophil biology have now produced clinically applicable therapies that seek to counter eosinophilia in blood and lungs. This article reviews the basic biology of eosinophils and their role in mediating T-helper 2 cell responses. The current status of anticytokine therapy for eosinophilic lung disease is discussed. A clinical approach to eosinophilic lung disease based on symptoms and radiography is generated. The clinical significance of persistent eosinophilia in lung transplant patients and patients with asthma will receive special emphasis.

AB - Eosinophils are involved in the pathogenesis of a number of lung diseases. Recent advances in eosinophil biology have now produced clinically applicable therapies that seek to counter eosinophilia in blood and lungs. This article reviews the basic biology of eosinophils and their role in mediating T-helper 2 cell responses. The current status of anticytokine therapy for eosinophilic lung disease is discussed. A clinical approach to eosinophilic lung disease based on symptoms and radiography is generated. The clinical significance of persistent eosinophilia in lung transplant patients and patients with asthma will receive special emphasis.

KW - Asthma

KW - Eosinophils

KW - Hypereosinophilic syndrome

KW - Interleukin 5

KW - Lung allograft rejection

UR - http://www.scopus.com/inward/record.url?scp=85032658173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032658173&partnerID=8YFLogxK

U2 - 10.1016/j.amjms.2017.03.020

DO - 10.1016/j.amjms.2017.03.020

M3 - Review article

C2 - 29078837

AN - SCOPUS:85032658173

VL - 354

SP - 339

EP - 349

JO - The American journal of the medical sciences

JF - The American journal of the medical sciences

SN - 0002-9629

IS - 4

ER -